Table 1.
Clinical and demographic variables for controls and sarcoidosis subjects for BAL cell studies.
| Controls (n = 4) | Sarcoidosis (n = 4) | p-value* | |
|---|---|---|---|
| Age (years) | 46 (39.5, 46.75) | 39.5 (36, 46.75) | 0.88 |
| Sex (M/F) | 2/2 | 2/2 | 1.00 |
| Race (AA/C) | 0/4 | 0/4 | |
| Smoking (smokers/non-smokers)# | 0/4 | 0/4 | |
| BAL WBC count/μL | 162 (122.5, 213.5) | 83.5 (42.75, 166.3) | 0.20 |
| BAL neutrophils (%) | 0.5 (0.27, 0.5) | 1.0 (1.0, 1.75) | 0.02 |
| BAL lymphocytes (%) | 5.1 (1.95, 9.375) | 33.0 (15.0, 54.25) | 0.03 |
| BAL macrophages (%) | 94.4 (90.35, 97.55) | 65 (44.75, 83.0) | 0.02 |
| Percent predicted FVC | 95 (84, 103.75) | ||
| Percent predicted FEV1 | 93 (85.7, 99.2) | ||
| Percent predicted DLCO | 111 (94.5,121) |
Date presented as median (IQR).
*Mann-Whitney test or Chi-square test.
#All subjects were non-smokers (controls: 1 never smoker, 2 former smoker and 1 prior smoking history not known; cases: 3 never smokers and 1 former smoker).